Dihydroartemisinin + Piperaquine for Oral Suspension

Active Ingredients: Dihydroartemisinin, Piperaquine

Dihydroartemisinin and Piperaquine are used for the treatment and prevention of malaria. This combination drug is used to treat malaria in individuals with suspected or confirmed infection, and for prevention of infection in individuals with no immunity to malaria who are visiting a malaria-endemic region.

Dihydroartemisinin is a derivative of artemisinin that has been added to Piperaquine, which is used as a prophylaxis. The combination is effective against malaria infections caused by P. Falciparum and P. vivax.

AdvaCare Pharma manufactures Dihydroartemisinin + Piperaquine for Oral Suspension in GMP-certified facilities located in China, India, and the USA. These production facilities are routinely inspected to ensure our products meet quality and safety standards.

AdvaCare Pharma, a GMP-compliant pharmaceutical company, specializes in the manufacture of Dihydroartemisinin + Piperaquine for Suspension. Our strategic manufacturing locations and innovative management systems ensure full control over the supply chain, resulting in enhanced quality standards and decreased costs throughout the production, transport and import processes. As a trusted Dihydroartemisinin + Piperaquine manufacturer, we globally supply a comprehensive range of 55+ oral liquid medicines in suspension dosage form to more than 65 countries.

What is Dihydroartemisinin + Piperaquine used for?

It is used to treat all forms of malaria, including multi-drug-resistant malaria.

How is Dihydroartemisinin + Piperaquine for Oral Suspension used?

The Dihydroartemisinin + Piperaquine for Oral Suspension is manufactured as an oral fixed-dose medication, which must be mixed in water for consumption.

What dose should be taken?

For adults and children weighing over 5 kg, the recommended dosing regimen for Dihydroartemisinin + Piperaquine for Oral Suspension is to take three doses over three consecutive days. This regimen consists of a total of three doses, one daily dose taken at the same time every day.

Refer to a doctor or pharmacist for guidelines on dosage. Do not exceed what they advise.

As with all pharmaceuticals, some unwanted effects can occur from the use of Dihydroartemisinin + Piperaquine.

Seek medical attention if the following develop: • cardiac arrhythmias

For a comprehensive list of all possible effects, consult a doctor.

If any symptoms persist or worsen, or you notice any other symptom, then please call your doctor immediately.

Consult with your doctor about any medications you are taking before your treatment with Dihydroartemisinin + Piperaquine.

There is little evidence with regard to the use of Dihydroartemisinin + Piperaquine during pregnancy or breastfeeding, so talk to a doctor or healthcare professional before taking the medicine.

Driving or operating machinery should be avoided, as this drug may cause dizziness.